Literature DB >> 7568100

Association of the "major histocompatibility complex subregion" I-J determinant with bioactive glycosylation-inhibiting factor.

T Nakano1, Y C Liu, T Mikayama, H Watarai, M Taniguchi, K Ishizaka.   

Abstract

Murine suppressor T-cell hybridoma cells (231F1) secrete not only bioactive glycosylation-inhibiting factor (GIF) but also an inactive peptide comparable to bioactive GIF peptide in its molecular size and reactivity with anti-GIF; the amino acid sequence of the inactive peptide is identical to that of the bioactive homologue. The inactive GIF peptide in culture supernatant of both the 231F1 cells and a stable transfectant of human GIF cDNA in the murine suppressor T hybridoma selectively bound to Affi-Gel 10, whereas bioactive GIF peptides from the same sources failed to bind to the gel. The inactive cytosolic human GIF from the stable transfectant and Escherichia coli-derived recombinant human GIF also had affinity for Affi-Gel 10. Both the bioactive murine GIF peptide from the suppressor T hybridoma and bioactive recombinant human GIF from the stable transfectant bound to the anti-I-J monoclonal antibody H6 coupled to Affi-Gel. However, bioactive hGIF produced by a stable transfectant of human GIF cDNA in BMT10 cells failed to be retained in H6-coupled Affi-Gel. These results indicate that the I-J specificity is determined by the cell source of the GIF peptide and that the I-J determinant recognized by monoclonal antibody H6 does not represent a part of the primary amino acid sequence of GIF. It appears that the epitope is generated by a posttranslational modification of the peptide.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7568100      PMCID: PMC40951          DOI: 10.1073/pnas.92.20.9196

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  24 in total

1.  I-J epitopes are adaptively acquired by T cells differentiated in the chimaeric condition.

Authors:  W Uracz; Y Asano; R Abe; T Tada
Journal:  Nature       Date:  1985 Aug 22-28       Impact factor: 49.962

Review 2.  I-J as an inducible T cell receptor for self.

Authors:  T Tada; W Uracz; R Abe; Y Asano
Journal:  Immunol Rev       Date:  1985-04       Impact factor: 12.988

Review 3.  Suppressor cells and immunoregulation.

Authors:  M E Dorf; B Benacerraf
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

4.  Biochemical identification of I-J as a novel dimeric surface molecule on mouse helper and suppressor T cell clones.

Authors:  T Nakayama; R T Kubo; H Kishimoto; Y Asano; T Tada
Journal:  Int Immunol       Date:  1989       Impact factor: 4.823

5.  Construction of antigen-specific suppressor T cell hybridomas from spleen cells of mice primed for the persistent IgE antibody formation.

Authors:  M Iwata; K Ishizaka
Journal:  J Immunol       Date:  1988-11-15       Impact factor: 5.422

6.  A monoclonal antibody raised to lipomodulin recognizes T suppressor factors in two independent hapten-specific suppressor networks.

Authors:  J K Steele; V K Kuchroo; H Kawasaki; S Jayaraman; M Iwata; K Ishizaka; M E Dorf
Journal:  J Immunol       Date:  1989-04-01       Impact factor: 5.422

Review 7.  Regulation of IgE synthesis.

Authors:  K Ishizaka
Journal:  Annu Rev Immunol       Date:  1984       Impact factor: 28.527

8.  Molecular cloning of a cDNA encoding a human macrophage migration inhibitory factor.

Authors:  W Y Weiser; P A Temple; J S Witek-Giannotti; H G Remold; S C Clark; J R David
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

9.  Carrier-specific suppression of antibody responses by antigen-specific glycosylation-inhibiting factors.

Authors:  P Jardieu; M Akasaki; K Ishizaka
Journal:  J Immunol       Date:  1987-03-01       Impact factor: 5.422

10.  IgE-binding factors from mouse T lymphocytes. III. Role of antigen-specific suppressor T cells in the formation of IgE-suppressive factor.

Authors:  P Jardieu; T Uede; K Ishizaka
Journal:  J Immunol       Date:  1984-12       Impact factor: 5.422

View more
  5 in total

1.  Cellular mechanisms for the formation of a soluble form derivative of T-cell receptor alpha chain by suppressor T cells.

Authors:  Y Ishii; T Nakano; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

2.  High-affinity binding of bioactive glycosylation-inhibiting factor to antigen-primed T cells and natural killer cells.

Authors:  K Sugie; T Nakano; T Tomura; K Takakura; T Mikayama; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-05-13       Impact factor: 11.205

3.  Posttranslational modification of the glycosylation inhibiting factor (GIF) gene product generates bioactive GIF.

Authors:  H Watarai; R Nozawa; A Tokunaga; N Yuyama; M Tomas; A Hinohara; K Ishizaka; Y Ishii
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

4.  Conversion of inactive glycosylation inhibiting factor to bioactive derivatives by modification of a SH group.

Authors:  T Nakano; H Watarai; Y C Liu; Y Oyama; T Mikayama; K Ishizaka
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

5.  The crystal structure of human glycosylation-inhibiting factor is a trimeric barrel with three 6-stranded beta-sheets.

Authors:  Y Kato; T Muto; T Tomura; H Tsumura; H Watarai; T Mikayama; K Ishizaka; R Kuroki
Journal:  Proc Natl Acad Sci U S A       Date:  1996-04-02       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.